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Background: Myeloperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritis (MPO-ANCA-GN)
and concurrent membranous nephropathy (MN) are very rare combination. Their causal relationship has been
suggested, but not determined.
Case presentation: A 73-years-old male with 5-year history of proteinuria underwent an operation for his sigmoid
colon cancer. Seven months later, he was referred to a nephrology division due to an exacerbating renal function
and hypoalbuminemia. Laboratory examination revealed positive MPO-ANCA in the serum. A renal biopsy revealed
a necrotizing extracapillary proliferative glomerulonephritis with crescents, demonstrating MPO-ANCA-GN. Whereas,
immunofluorescent staining documented granular deposition of immumoglobulin (Ig) G and C3 along the capillary
wall and electron microscopy showed subepithelial deposits in the glomerular basement membrane demonstrating
MN. Immunofluorescent staining of IgG subclass showed positive IgG1, IgG2, negative IgG3 and weak positive IgG4
suggested the possibility of malignancy-associated MN.
Conclusion: Combination of MPO-ANCA-GN and MN are rare. Although the causal relationship has been suggested
in some cases, we should consider all the possibilities including idiopathic MN and secondary MN associated with
malignancy, drug use or infection.
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Anti-neutrophil cytoplasmic antibody-associated glomer-
ulonephritis (ANCA-GN) is usually characterized by nec-
rotizing and crescentic glomerulonephritis without the
deposition of immunoglobulin and complement, therefore,
it is called pauci immune type. Whereas, immunoglobulin
depositions have been sometimes observed [1] and very
rare cases of membranous nephropathy (MN) and the
concurrent ANCA-GN and have been suggested [2-6].
The precise mechanism of the combination of these two
etiologies is not clear due to the limited numbers of the* Correspondence: mshimada@cc.hirosaki-u.ac.jp
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reproduction in any medium, provided the orpatients. Here we describe a case of myeloperoxidase
(MPO)-ANCA-GN complicated with MN developed in
73-years-old male.Case presentation
A 73-years-old male underwent a curative operation for a
well-differentiated adenocarcinoma of the sigmoid colon.
The tumor was (T2) with no lymphatic invasion (N0) and
no distant metastasis (M0). Seven months later, he was re-
ferred to a nephrology division and admitted due to an ex-
acerbating renal function and hypoalbuminemia without
any clinical symptoms other than edema in the lower ex-
tremities. He had been diagnosed with hypertension, vaso-
spastic angina and gastric ulcer for 11 years and treated
with olmesartan medoxomil, nicorandil and roxatidineal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Light microscopic findings. Periodic acid-Schiff’s staining reveal a necrotizing extracapillary proliferative glomerulonephritis with
crescent and many infiltrated mononuclear cells in the tubulointerstitium (A: original magnification × 200). A glomerulus with fibrocellular
crescent and thickened glomerular basement membrane (GBM) (B: original magnification × 400). A glomerulus with fibrocellular crecent and
thickened glomerular basement membrane (GBM) (Periodic acid-Schiff’s stain, original magnification × 400).
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++). At the time of the pre-operative examinations, there
was no specific symptoms. Serum creatinine was stable
(1.2 mg/dl), C-reactive protein (CRP) was negative, pro-
teinuria(++) and microhematuria was absent. Laboratory
values at the time of referral are as follows: hemoglobin
10.1 g/dL, total protein 6.7 g/dL, albumin 3.1 g/dL, lactate
dehydrogenase 208 U/L, blood urea nitrogen 59 mg/dL,
creatinine 5.4 mg/dL, CRP 0.88 mg/dL, carcinoembryonic
antigen (CEA) 4.1 ng/ml (negative), carbohydrate antigen
(CA) 19–9 <1 U/ml (negative), MPO-ANCA >640 EU
(positive), PR3-ANCA tested by ELISA <10 EU (nega-
tive), anit-glomerular besement membrane (GBM) anti-
body <10 EU (negative), anti nuclear antibody ×40
(normal limit < ×40), C3 97mg/dl, C4 59mg/dl. Urinaly-
sis showed hematuria (+++): sediment red blood cells
40 /high power field and proteinuria 2.3 g/day. Chest
CT scan revealed no specific findings. A renal biopsy was
performed and documented a necrotizing extracapillary
proliferative glomerulonephritis. There were 11 glom-
eruli, 5 with global sclerosis, 8 with mostly segmental
crescents (5 fibro-cellular, 3 cellular) (Figure 1A, B).
Routine immunofluorescent analysis revealed granularFigure 2 Immunofluorescent staining for IgG(A) and C3(B) reveals gra
(original magnification × 400).immumoglobulin G (IgG) and C3 deposition along
the glomerular capillary wall (Figure 2A, B). IgA,
IgM and fibrionogen were negative. Glomerular IgG
subclass determined by immunofluorescent analysis
showed positive IgG1 and IgG2, negative IgG3 and
weak positive IgG4 deposition (Figure 3 A-D). Elec-
tron microscopy revealed electron-dense deposits in
the subepithelial area of the GBM suggesting stage
3 MN (Figure 4).
3 week pulse therapy with methylprednisolone (500
mg for 3 days/week) followed by oral prednisolone
(30 mg/day) decreased the levels of serum MPO-
ANCA to normal range. Microhematuria was dis-
appeared and CRP became negative, however, the
levels of proteinuria and renal function did not im-
prove. In a month, the antigenemia of the cytomegalo-
virus became positive without any clinical symptoms
and was treated with valganciclovir. Therefore, pred-
nisolone was tapered without adding immunosuppres-
sants. Hemodialysis was initiated 6 months after the
diagnosis of MPO-ANCA-GN. There was no recur-
rence of colon cancer and MPO-ANCA remained
negative during the follow-up.nular deposition in the glomerular capillary wall
Figure 3 Immunofluorescent staining for IgG subclass. IgG1(A) and IgG2(B) reveals granular deposition in the glomerular capillary wall.
IgG3(C) was negative and IgG4(D) was weak positive (original magnification × 400).
Figure 4 Electron microscopy shows electron dense deposits in
subepithelial area of GBM (original magnification × 5000).
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MN and concurrent MPO-ANCA-GN are very rare
combination. It has been a question whether this is just
a coincidence or there is a causal relationship. Recently,
Hamamura et al. showed that MPO-ANCA-GN may
cause MN-like lesions by demonstrating partial co-
localization of MPO and IgG within the electron dense
deposits [7]. There are also several characteristics
observed in concurrent MN and ANCA-GN. Granular
deposition of IgG and C3 along the GBM is similar, but
IgG subclass deposition is different from predominant
IgG4 pattern in idiopathic-MN and IgG1 and IgG4
depesition is reported in several cases [6,7]. This is com-
patible with the fact that the serum subclass of MPO-
ANCA consisted mainly of IgG1 and IgG4 [8]. Besides,
the electron microscopy findings show irregular dense
deposits different from the global pattern of the
idiopathic-MN. Due to the small numbers of the cases,
further investigation is necessary for further understand-
ing of the relationship between these two etiologies. In
most cases, these two etiologies found concurrently,
therefore, causal relationship is quite probable [2,5,7].
On the other hand, this may not explain all the cases, es-
pecially when MN and ANCA-GN diagnosed at different
time course. In some cases, MPO-ANCA-GN was found
during the remission of the MN [3,5]. These cases may
be truly coincidental occurrence of the idiopathic-MN
and MPO-ANCA-GN. Additionally, other causes such
as malignancy-associated, infection-associated and drug-
induced MN should be considered as well. In our case,MN and MPO-ANCA-GN were diagnosed simultan-
eously, but the long duration of the proteinuria and the
colon cancer suggested the possibility of malignancy
associated-MN which presumably preceded MPO-ANCA
-GN at least to some extent. Electron microscopy findings
also showed dense deposits of stage 3, relatively old lesion
of MN. Additionally, predominant IgG1 and IgG2 depos-
ition also suggested that MN in our case was secondary
MN due to malignancy [9]. However, since we could not
see the obvious improvement of proteinuria after the sur-
gery of the colon cancer, we could not definitively diag-
nose that this case was malignancy associated-MN. Thus,
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different etiologies. Precise observation of these cases,
especially the onset of the diseases, the analysis of IgG
subclass in the glomerular deposition and the examination
for the existence of the anti M-type phospholipase A2 re-
ceptor antibody which is demonstrated as the cause of
idiopatic-MN also would help further understanding of
these cases [10].
Conclusions
Causal relationship has been suggested in the combin-
ation of MPO-ANCA-GN and MN in some cases, how-
ever, we should consider all the possibilities including
malignancy, drug or infection associated MN as well as
idiopathic MN. Besides, the analysis of the IgG subclass
in the glomerular deposition may be of help.
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